Immunotherapy prolongs the serum CEA–TPA–CA15.3 lead time at the metastatic progression in endocrine-dependent breast cancer patients: A retrospective longitudinal study-Reference-Cited by-同舟云学术

Immunotherapy prolongs the serum CEA–TPA–CA15.3 lead time at the metastatic progression in endocrine-dependent breast cancer patients: A retrospective longitudinal study

Published:2008-05 Issue:1 Volume:263 Page:122-129
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Nicolini A.,Carpi A.,Ferrari P.,Rossi G.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference26 articles.

1. Postoperative follow-up of breast cancer patients: overview and progress in the use of tumor markers;Nicolini;Tumour Biol.,2000

2. Utility of a serum tumour marker panel in the post-operative follow-up of breast cancer patients with equivocal conventional radiological examinations;Nicolini;Tumour Biol.,2003

3. Prolonged survival by’early’ salvage treatment of breast cancer patients: a retrospective 6-year study;Nicolini;Br. J. Cancer,1997

4. Beta-interferon and interleukin-2 prolong more than three times the survival of 26 consecutive endocrine dependent breast cancer patients with distant metastases: an exploratory trial;Nicolini;Biomed. Pharmacother.,2005

5. An immunotherapy schedule in endocrine-dependent metastatic breast cancer: correlation between clinical course and immunologic parameters;Nicolini;J. Immunother.,2005

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experimental and clinical evidence in favour of an effective immune stimulation in ER-positive, endocrine-dependent metastatic breast cancer;Frontiers in Immunology;2024-01-25

2. A Hormone Immunotherapy (HIT) Combination in Advanced Breast Cancer;Interdisciplinary Cancer Research;2022

3. Exploring the value of pleural fluid biomarkers for complementary pleural effusion disease examination;Computational Biology and Chemistry;2021-10

4. Treatment of Metastatic or High-Risk Solid Cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports;International Journal of Molecular Sciences;2019-11-28

5. Tumour growth and immune evasion as targets for a new strategy in advanced cancer;Endocrine-Related Cancer;2018-11